Orion Group 2004 Financial Statements
February 14, 2005 11:31 ET
|
Orion Oyj
Orion Pharma accounted for EUR 100.2 million, or 78% of the total. Group net sales decreased by 14.0% to EUR 1,944.3 (2,261.5) million due to structural changes in the Group and lower net sales of the...
Tiedote Orion Oyj:n tilinpäätöksestä vuodelta 2004
February 14, 2005 11:31 ET
|
Orion Oyj
Orion Pharman osuus liikevoitosta oli 100,2 milj. EUR eli 78 %. Konsernin liikevaihto oli 1 944,3 (2 261,5) milj. EUR, muutos -14,0 %. Lasku aiheutui konsernin muuttuneesta rakenteesta...
Jorge Calvet, Chairman of Fortis Bank Iberia and Country Manager, to resign
February 14, 2005 11:30 ET
|
Ageas
After an international career in banking with Bankers' Trust (New York), Morgan Stanley (London) and UBS (Spain), Jorge Calvet joined Fortis in 2001, where he was responsible for integrating...
Jorge Calvet, bestuursvoorzitter van Fortis Bank Iberia en Country Manager, kondigt vertrek aan
February 14, 2005 11:30 ET
|
Ageas
Na een internationale bankcarrière bij Bankers Trust (New York), Morgan Stanley (Londen) en UBS (Spanje) trad Jorge Calvet in 2001 in dienst bij Fortis, belast met de verantwoordelijkheid voor...
Jorge Calvet démissionne de ses postes de Président de Fortis Bank Iberia et de Country Manager
February 14, 2005 11:30 ET
|
Ageas
Après une carrière bancaire internationale au sein de Bankers' Trust (New York), Morgan Stanley (Londres) et UBS (Espagne), Jorge Calvet a rejoint Fortis en 2001 où il a été chargé de...
Bach-Hauser Has Changed Its Name To Financial Access Solutions Technology, Inc.
February 14, 2005 11:20 ET
|
Financial Access Solutions Technology, Inc.
MONTREAL, Feb. 14, 2005 (PRIMEZONE) -- Bach-Hauser has changed its name to Financial Access Solutions Technology, Inc. (Pink Sheets:FLST). On February 8, 2005, Bach-Hauser, Inc. filed a Certificate...
ViroPharma Announces Start of HCV-796 Phase 1 Program
February 14, 2005 11:15 ET
|
ViroPharma Incorporated
EXTON, Pa., Feb. 14, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that dosing has begun in the Phase 1 clinical trial for HCV-796, a novel polymerase inhibitor being...
New Jersey Mining Company Finds Geophysical Anomalies at Silver Strand
February 14, 2005 11:09 ET
|
New Jersey Mining Company
KELLOGG, Idaho, Feb. 14, 2005 (PRIMEZONE) -- New Jersey Mining Company (OTCBB:NJMC) announces that an extensive geophysical and geochemical exploration program has been completed at its Silver Strand...
UAW Rejects New Agreements with Volvo Trucks North America
February 14, 2005 11:06 ET
|
Volvo
GOTEBORG, Sweden, Feb. 14, 2005 (PRIMEZONE) -- Volvo Trucks North America, Inc., announced that employees represented by the United Auto Workers yesterday rejected two of three tentative labor...
Cubic Energy, Inc. Fracture Treated Its Moseley 26 No. 1 Well
February 14, 2005 11:05 ET
|
Cubic Energy, Inc.
DALLAS, Feb. 14, 2005 (PRIMEZONE) -- Cubic Energy, Inc. (OTCBB:QBIK) announced today that it has recently completed the Taylor Sand of the Cotton Valley in the Moseley 26 No. 1 well in DeSoto Parish,...
- August 10, 2024 09:17 ET WEEX to Participate in FORESIGHT 2024 Hong Kong Summit on August 11 as a Leading CEX Sponsor
- August 09, 2024 20:15 ET Silly Nice Achieves #2 Spot in New York Concentrates Market with Diamond Powder